LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Inventory Summary of LegoChem Biosciences, Inc.

  • LegoChem Biosciences, Inc.'s latest annual inventory in 2023 was 196.83 Million KRW , down -1.0% from previous year.
  • LegoChem Biosciences, Inc.'s latest quarterly inventory in 2024 Q2 was 209.72 Million KRW , down -35.45% from previous quarter.
  • LegoChem Biosciences, Inc. reported annual inventory of 198.81 Million KRW in 2022, down -26.51% from previous year.
  • LegoChem Biosciences, Inc. reported annual inventory of 270.54 Million KRW in 2021, down -5.22% from previous year.
  • LegoChem Biosciences, Inc. reported quarterly inventory of 324.91 Million KRW for 2024 Q1, up 65.07% from previous quarter.
  • LegoChem Biosciences, Inc. reported quarterly inventory of 171.29 Million KRW for 2023 Q1, down -13.84% from previous quarter.

Annual Inventory Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Inventory of LegoChem Biosciences, Inc. (2023 - 2016)

Year Inventory Inventory Growth
2023 196.83 Million KRW -1.0%
2022 198.81 Million KRW -26.51%
2021 270.54 Million KRW -5.22%
2020 285.44 Million KRW -85.88%
2019 2.02 Billion KRW 167.84%
2018 754.7 Million KRW -19.38%
2017 936.13 Million KRW 113.18%
2016 439.13 Million KRW 0.0%

Peer Inventory Comparison of LegoChem Biosciences, Inc.

Name Inventory Inventory Difference
HLB Co., Ltd. 11.42 Billion KRW 98.277%
iNtRON Biotechnology, Inc. 1.01 Billion KRW 80.533%
BINEX Co., Ltd. 28.26 Billion KRW 99.304%
Bioneer Corporation 41.35 Billion KRW 99.524%
Anterogen.Co.,Ltd. 1.91 Billion KRW 89.697%
MEDIPOST Co., Ltd. 14.51 Billion KRW 98.644%
CrystalGenomics, Inc. 1.55 Billion USD 87.34%
Helixmith Co., Ltd 914.11 Million KRW 78.467%
Chabiotech Co.,Ltd. 34.11 Billion KRW 99.423%
Medy-Tox Inc. 59.61 Billion KRW 99.67%
Peptron, Inc. 172.18 Million KRW -14.314%
Amicogen, Inc. 46.83 Billion KRW 99.58%
Genexine, Inc. 3.8 Billion KRW 94.83%
HLB Therapeutics Co.,Ltd. 5.33 Billion KRW 96.311%
ALTEOGEN Inc. 1.06 Billion KRW 81.576%
PharmaResearch Co., Ltd. 50.23 Billion KRW 99.608%
SillaJen, Inc. 1.21 Billion KRW 83.768%
JETEMA, Co., Ltd. 12.74 Billion KRW 98.455%
OliX Pharmaceuticals,Inc 468.4 Million KRW 57.978%
Genomictree Inc. 496.53 Million KRW 60.358%
MedPacto, Inc. 620.00 KRW -31747382.742%
D&D Pharmatech 3.45 Billion KRW 94.295%
EASY BIO,Inc. 25.93 Billion KRW 99.241%
GI Innovation, Inc. - KRW -Infinity%